Cowen Financial Products LLC 13D and 13G filings for Exagen Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-02 3:16 pm Sale |
2023-12-29 | 13G | Exagen Inc. XGN |
Cowen Financial Products LLC | 898,630 5.270% |
-67,392 (-6.98%) |
Filing |
| 2023-01-23 5:13 pm Sale |
2022-12-30 | 13G | Exagen Inc. XGN |
Cowen Financial Products LLC | 966,022 5.920% |
-418,609 (-30.23%) |
Filing |
| 2022-01-20 10:46 am Unchanged |
2021-12-31 | 13G | Exagen Inc. XGN |
Cowen Financial Products LLC | 1,384,631 8.570% |
0 (Unchanged) |
Filing |
| 2022-01-19 4:21 pm Purchase |
2021-12-31 | 13G | Exagen Inc. XGN |
Cowen Financial Products LLC | 1,384,631 8.570% |
511,000 (+58.49%) |
Filing |
| 2021-12-17 3:57 pm Purchase |
2021-09-10 | 13G | Exagen Inc. XGN |
Cowen Financial Products LLC | 873,631 5.410% |
873,631 (New Position) |
Filing |